PEACE · Perioperative Conscious Sedation During Endovascular Thrombectomy in Acute Ischemic Stroke
Trial completed
Jinling Hospital, ChinaPhase 4 NCT06139692 Registry history of NCT06139692 on ClinicalTrials.gov (opens the registry)
4 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 4 with minor changes only.
Trial completed
Jinling Hospital, ChinaPhase 4 NCT06139692 Registry history of NCT06139692 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Oct 2026 to Dec 2026
Also in this update: Enrollment increased: 146 → 162 participants
Jinling Hospital, ChinaPhase 2 NCT07672860 Registry history of NCT07672860 on ClinicalTrials.gov (opens the registry)
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Jinling Hospital, ChinaEarly Phase 1 NCT06612411 Registry history of NCT06612411 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Jinling Hospital, ChinaNot applicable NCT06619808 Registry history of NCT06619808 on ClinicalTrials.gov (opens the registry)
Changed
Registry verification sweep
Changed
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-16 | NCT07878026 This is a Single-center, Prospective, Single-arm Clinical Study Designed to Evaluate the… | Early Phase 1 | Not Yet Recruiting |
| 2026-10-14 | NCT07873502 HMG Treatment Reduces Sperm DNA Fragmentation | Phase 1 | Completed |
| Early Phase 1 | 2 | |
| Phase 2 | 9 | |
| Phase 4 | 1 |
Kidney Cancer (10) · Stroke (3) · Crohn's Disease (2) · Heart Disease (2) · Liver Cancer (2) · Pancreatic Cancer (2) · Bladder Cancer (1) · Chronic Kidney Disease (1) · Coronary Artery Disease (1) · Gastric Cancer (1)